Literature DB >> 32354555

Prevalence of late diagnosis of HIV infection.

Magda Muelas Fernandez1, Jhon Fredy Rojas Lievano2, Rafel Perez Vidal3, Antonia Flor Perez3, Alfons Tapiz Reula3, Josep Mallolas Masferrer4.   

Abstract

BACKGROUND: Prevalence of late diagnosis (LD) and identifying missed opportunities.
METHODS: Retrospective observational study of new HIV diagnoses between 2013 and 2018 in our referral area. Sociodemographic and clinical-analytical variables were analysed at the time of diagnosis. The patient's clinical history in the last 5 years before the HIV diagnoses was reviewed to identify missed opportunities for early diagnosis.
RESULTS: Seventy-four patients were included. The prevalence of LD was 44.6%, and 23% as an advanced disease. A tendency for LD was observed in patients older than 40 years, especially among Spaniards. Being tested 11for HIV protected against LD. All patients who had previous contact with the health system had clinical indicators or risk factors associated with HIV, but only 50% had ever been tested in their lifetime of HIV.
CONCLUSIONS: In spite of multiple contacts with our health system, almost half of the new cases of HIV infection are diagnosticated late. Different strategies should be implemented to improve the identification of the risk factors and clinical indicators of possible HIV infection.
Copyright © 2020 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Detección precoz; Diagnóstico tardío; Early detection; Factores de riesgo; Human Immunodeficiency Virus (HIV); Late diagnosis; Risk factors; Virus de la inmunodeficiencia humana (VIH)

Mesh:

Year:  2020        PMID: 32354555     DOI: 10.1016/j.medcli.2020.01.029

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

Review 1.  AIDS cases in Ottawa: A review of simultaneous HIV and AIDS diagnoses.

Authors:  Lauren Orser; Patrick O'Byrne; Dave Holmes
Journal:  Public Health Nurs       Date:  2022-03-19       Impact factor: 1.770

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.